Facebook
Instagram
Twitter
YouTube
RSS Feed
LinkedIn
Flickr
California's Stem Cell Agency
California Institute for Regenerative Medicine
For Researchers
Funding Opportunities
Information for Applicants
All Funding Opportunities
COVID-19
Discovery
Translational
Clinical
Infrastructure
Education
Previous Funding Opportunities
Grants
Active Awards Portfolio Dashboard
CIRM Grants
Managing Your Grant
CIRM Grantees
CIRM-Funded Institutions
CIRM Funding Commitments
Stem Cell Grant Regulations
Clinical Resources
CIRM Funded Clinical Trials
Alpha Clinics
Cell and Gene Therapy Center
Collaborative Funding Partnerships
Research Resources
FAQs for CIRM Awards
Industry Alliance Program
iPSC Repository
Genomics Initiative
CIRM Publications
Grantee Publications
Webinars and Workshops
hESC Cell Lines
For Patients
Patient Resources
CIRM Funded Clinical Trials
Alpha Stem Cell Clinics
Stem Cell Champions
Disease Programs
Stories of Hope
CIRM Stem Cellar Blog
Stem Cell Videos
Stem Cell Basics
Stem Cell Key Terms
Creating New Types of Stem Cells
Accelerating Research Towards Cures
California: The Leader in Stem Cell Research
From Lab Bench to Bedside
Myths and Misconceptions About Stem Cell Research
Stem Cell Tourism
The Power of Stem Cells
Patient Toolbox
Get Involved
Talking About CIRM
Jargon-Free Glossary
Media Interviews
Delivering the Perfect Presentation
Moderating a Panel
Serving on a Panel
Participating in Clinical Trials
Our Impact
Impact
Active Awards Dashboard
Funding Clinical Trials
Return on Investment
Creating Jobs
Creating Infrastructure
Growing the Field
Strategic Plan
Education
Internship programs (Bridges & SPARK)
Education Portal
Training Tomorrow's Scientists
Community
Stem Cell Champions
Stem Cell Awareness Day
Get Involved
About CIRM
About Us
Our Mission
Leadership
Our History
Annual Reports
CIRM FAQ
Where CIRM funding goes
Job Opportunities
Contact Us
Governing Board
Public Meetings
CIRM Resources
Annual Report
Strategic Plan
Funding Opportunities
Administrative Policies and Forms
News and Events
Newsroom
Meetings & Events
Public Meetings and Events
CIRM Board Meetings
Blog
Multimedia Resources
Podcast
Videos
Images
CIRM Fact Sheet
Logos
Contact Us
Search form
Search
You are here
Home
› University of California, San Francisco
University of California, San Francisco
Total Awards:
106
Award Value:
$252,684,214
Major Facility Name:
Ray and Dagmar Dolby Regeneration Medicine Building
Institution type:
Not for profit
Short Name:
UCSF
Share
Awards to the Institution
Program
Investigator
Award Title
Award Value
New Faculty Physician Scientist
Tippi MacKenzie
In Utero Embryonic Stem Cell Transplantation to Treat Congenital Anomalies
$2,661,742
Tools and Technologies III
Andrew Leavitt
Small molecule tools and scale-up technologies to expand human umbilical cord blood stem and progenitor cells for clinical and research use
$1,416,600
Conference
Susan Fisher
The Stem Cell Niche in Development and Disease
$5,000
Conference
Emmanuelle Passegue
CA-HSCI 1st Generation Stem Cell PI Meeting
$20,000
Conference II
David Rowitch
“Myelin Through the Ages: Evolution, Development, Degeneration and Disease” - 2018 Gordon Research Conference (GRC) and Gordon Research Seminar (GRS)
$10,000
Alpha Stem Cell Clinics Network Expansion
Mark Walters
University of California, San Francisco (UCSF) CIRM Alpha Stem Cell Clinic
$5,707,388
New Cell Lines
Miguel Ramalho-Santos
Somatic cell age and memory in the generation of iPS cells
$1,307,201
Research Training Grant
Robert Blelloch
Scholars Research Training Program in Regenerative Medicine, Gene Therapy, and Stem Cell Research
$5,000,000
SEED Grant
Valerie Weaver
Force, Dimensionality and Stem Cell Fate
$529,762
Foundation - Discovery Stage Research Projects
Harold Chapman
Modulation of human alveolar stem cells to promote lung regeneration and avoid pulmonary fibrosis
$1,626,001
Comprehensive Grant
Randall Lee
Embryonic Stem Cell-Derived Therapies Targeting Cardiac Ischemic Disease
$2,424,353
Transplantation Immunology
Tippi MacKenzie
Maternal and Fetal Immune Responses to In Utero Hematopoietic Stem Cell Transplantation
$1,230,869
Early Translational III
Morton Cowan
Gene Correction of Autologous Hematopoietic Stem Cells in Artemis Deficient SCID
$3,862,367
Tissue Collection for Disease Modeling
Jacquelyn Maher
iPSC-derived Hepatocytes as Platforms for Research in Viral Hepatitis and Non-alcoholic Steatohepatitis
$791,680
SPARK
Katherine Nielsen
Developing High School Students' Research Practices and Regenerative Medicine Knowledge through a Summer Intern Program
$382,430
Conference
Regis Kelly
The Science of Staying Younger Longer
$6,500
Conference
Diana Laird
The 2014 Santa Cruz Developmental Biology Meeting
$3,000
Clinical Trial Stage Projects
Morton Cowan
Gene Transfer for Artemis-Deficient Severe Combined Immunodeficiency Using a Lentiviral Vector to Transduce Autologous CD34 Hematopoietic Stem Cells
$12,000,000
Therapeutic Translational Research Projects
Mark Walters
Curing Sickle cell Disease with CRISPR-Cas9 genome editing
$60,635
SEED Grant
Robert Blelloch
MicroRNA Regulation of Human Embryonic Stem Cell Self-Renewal and Differentiation
$605,886
Therapeutic Translational Research Projects
Hideho Okada
Development of novel synNotch CART cell therapy in patients with recurrent EGFRvIII+ glioblastoma
$4,556,536
SEED Grant
Linda Giudice
Human Embryonic Stem Cell Differentiation to Trophoblast: Basic Biology and Clinical Translation to Improve Human Fertility
$614,784
Foundation - Discovery Stage Research Projects
Robert Blelloch
Development of universal off-the-shelf iPSC derived dendritic cells for use as patient specific anti-tumor vaccine
$1,391,999
Comprehensive Grant
Harold Bernstein
Modeling Myocardial Therapy with Human Embryonic Stem Cells
$2,134,694
Tools and Technologies II
Daniel Lim
Development and preclinical testing of new devices for cell transplantation to the brain.
$1,795,891
Basic Biology IV
Barbara Panning
Investigation of the role of O-GlcNAcylation in SOX2 function during reprogramming
$1,260,037
Basic Biology V
Mark Anderson
Generation of a functional thymus to induce immune tolerance to stem cell derivatives
$1,191,000
Inception - Discovery Stage Research Projects
Andrew Brack
Examining the efficacy of GDF11 antibody as a rejuvenator of aged human muscle stem cell capacity and muscle repair .
$180,000
Conference
Jeffrey Rosenfeld
California ALS Research Summit 2014
$8,563
Patent Assistance Fund Awards
Karin Immergluck
Patent Assistance Fund Proposal - UCSF
$87,257
Late Stage Preclinical Projects
Krystof Bankiewicz
MRI Guided Delivery of Neural Progenitor Cells Secreting GDNF for the Treatment of Parkinson's disease
$5,811,340
Basic Biology II
John Rubenstein
MGE Enhancers to Select for Interneuron Precursors Produced from Human ES Cells
$1,387,800
Clinical Trial Stage Projects
Michael Matthay
Mesenchymal Stromal Cells for ARDS (COVID positive and COVID negative)
$701,049
SEED Grant
Su Guo
Identifying small molecules that stimulate the differentiation of hESCs into dopamine-producing neurons
$542,619
Therapeutic Translational Research Projects
Arun Wiita
CD72 nanoCARs for the treatment of refractory pediatric B-cell acute lymphoblastic leukemia
$3,330,801
New Faculty II
Robert Blelloch
Mechanisms of small RNA regulation in early embryonic development
$2,790,695
Alpha Stem Cell Clinics Network Expansion
Mark Walters
University of California, San Francisco (UCSF) Alpha Stem Cell Clinic (ASCC)
$7,994,347
Comprehensive Grant
Samuel Pleasure
Human stem cell derived oligodendrocytes for treatment of stroke and MS
$2,459,235
Basic Biology III
Jason Pomerantz
Phenotypic Analysis of Human ES Cell-Derived Muscle Stem Cells
$1,381,296
Basic Biology IV
Miguel Ramalho-Santos
Genetic dissection of human cellular reprogramming to pluripotency
$1,184,883
Basic Biology V
Valerie Weaver
Biophysical Determinants of Early Embryonic Stem Cell Fate Specification
$1,186,500
Inception - Discovery Stage Research Projects
Holger Willenbring
Generation of bile duct-competent transplantable human liver organoids
$206,460
Conference
Tippi MacKenzie
In Utero Hematopoietic Stem Cell Transplantation and Maternal-Fetal Tolerance
$17,526
Inception - Discovery Stage Research Projects
Sonja Schrepfer
Hypo-immunogenic cardiac patches for myocardial regeneration
$235,818
Quest - Discovery Stage Research Projects
Hideho Okada
Non-viral reprogramming of the endogenous TCRα locus to direct stem memory T cells against shared neoantigens in malignant gliomas
$900,000
Early Translational II
Arturo Alvarez-Buylla
Inhibitory Nerve Cell Precursors: Dosing, Safety and Efficacy
$1,564,016
Clinical Trial Stage Projects
Steven Deeks
Anti-HIV duoCAR-T cell therapy for HIV infection
$8,970,732
SEED Grant
Holger Willenbring
Induction of pluripotency in fibroblasts by fusion with enucleated human embryonic stem cell syncytia
$329,245
SPARK
Katherine Nielsen
Stem Cell Summer Research Experiences
$508,750
New Faculty II
Holger Willenbring
Molecular dissection of adult liver regeneration to guide the generation of hepatocytes from pluripotent stem cells
$2,832,008
Late Stage Preclinical Projects
Karin Gaensler
Development of TriLeukeVax, an Engineered Autologous Leukemia Vaccine for Stimulating Cytolytic Immune Responses to Residual Leukemic Stem Cells
$6,000,000
Comprehensive Grant
Arnold Kriegstein
Derivation of Inhibitory Nerve Cells from Human Embryonic Stem Cells
$2,410,874
Basic Biology III
John Murnane
Genomic instability during culturing of human embryonic stem cells
$1,070,919
Basic Biology IV
Jeremy Reiter
Modeling disease in human embryonic stem cells using new genetic tools
$1,387,800
Major Facilities
A. Washington
UCSF CIRM Building
$34,862,400
Late Stage Preclinical Projects
Jennifer Puck
Ex Vivo Transduction of the Human Artemis (DCLRE1C) cDNA by Lentiviral Vector AProArt into CD34+ Hematopoietic Cells for Artemis (ART)-Deficient Severe Combined Immunodeficiency (SCID)
$4,268,865
Conference
Jason Rock
Tri-Institutional Stem Cell Retreat
$3,500
Quest - Discovery Stage Research Projects
Holger Willenbring
Preclinical development of AAV vector-mediated in vivo hepatic reprogramming of myofibroblasts as a therapy for liver fibrosis
$1,638,389
Therapeutic Translational Research Projects
Karin Gaensler
Developing engineered autologous leukemia vaccines to target residual leukemic stem cells
$4,171,728
Early Translational II
Markus Muschen
Dual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication
$2,756,536
Diagnostic Translational Research Projects
Steven Mack
Development of a Noninvasive Prenatal Test for Beta-Hemoglobinopathies for Earlier Stem Cell Therapeutic Interventions
$633,014
SEED Grant
Didier Stainier
Endodermal differentiation of human ES cells
$611,027
Quest - Discovery Stage Research Projects
Julia Carnevale
Generating deeper and more durable BCMA CAR T cell responses in Multiple Myeloma through non-viral knockin/knockout multiplexed genome engineering
$1,463,368
New Faculty II
Jeremy Reiter
High throughput modeling of human neurodegenerative diseases in embryonic stem cells
$2,259,092
Comprehensive Grant
Susan Fisher
Constructing a fate map of the human embryo
$2,430,487
Research Training II
Susan Fisher
Training Program in Stem Cell Research at UCSF
$7,814,027
Creativity Awards
Katherine Nielsen
UCSF SEP High School Intern Program
$168,947
Disease Team Planning
Jeffrey Bluestone
A CIRM Disease Team for the Treatment and Cure of Diabetes
$55,000
Quest - Discovery Stage Research Projects
Tejal Desai
Thin Film Encapsulation Devices for Human Stem Cell derived Insulin Producing Cells
$1,092,063
Conference
Brian Black
Weinstein Cardiovascular Development Conference
$35,000
Clinical Trial Stage Projects
Tippi MacKenzie
In Utero Hematopoietic Stem Cell Transplantation For The Treatment Of Fetuses With Alpha Thalassemia Major
$10,906,978
Conference - The 2019 Alpha Stem Cell Clinic Annual Symposium
Mark Walters
2019 Alpha Stem Cell Clinic Symposium - Mending Stem Cells: The Past, Present & Future Regenerative Medicine
$60,000
Disease Team Research I
Mitchel Berger
Stem Cell-Mediated Oncocidal Gene Therapy of Glioblastoma (GBM)
$6,214,914
Therapeutic Translational Research Projects
Hideho Okada
Development of novel synNotch CART cell therapy in patients with recurrent EGFRvIII+ glioblastoma
$525,000
SEED Grant
Heike Daldrup-Link
Labeling of human embryonic stem cells with iron oxide nanoparticles and fluorescent dyes for a non-invasive cell depiction with MR imaging and optical imaging
$240,214
Quest - Discovery Stage Research Projects
Julie Saba
Providing a cure for sphingosine phosphate lyase insufficiency syndrome (SPLIS) through adeno-associated viral mediated SGPL1 gene therapy
$1,463,400
New Faculty II
Ophir Klein
Laying the groundwork for building a tooth: analysis of dental epithelial stem cells
$3,075,251
Shared Labs
Linda Giudice
The University of California San Francisco Shared Research and Teaching Laboratory: a Non-Federal Human Embryonic Stem Cell Resource for the Bay Area Community
$3,289,649
Training Grant I-1
Susan Fisher
Training Grant I
$2,868,145
New Faculty Physician Scientist
Ophir Klein
Stem cell therapy for inflammatory bowel disease
$3,019,013
New Faculty Physician Scientist
Jason Pomerantz
Characterization of Human Skeletal Muscle Stem Cells for Clinical Application
$2,959,014
Disease Team Planning
Jeffrey Lotz
A CIRM Disease Team for the Repair of Traumatically Injured and Arthritic Cartilage
$33,172
Quest - Discovery Stage Research Projects
Julie Sneddon
Designing a cellular niche for transplantation of human embryonic stem cell-derived beta cells
$2,006,076
Conference
Arnold Kriegstein
UCSF Frontiers of Neural Stem Cells Symposium
$35,000
Inception - Discovery Stage Research Projects
Semil Choksi
Generation of human airway stem cells by direct transcriptional reprogramming for disease modeling and regeneration
$238,408
Late Stage Preclinical Projects
Mark Walters
Curing Sickle cell Disease with CRISPR-Cas9 genome editing
$2,242,805
New Cell Lines
Susan Fisher
Optimization of Human Embryonic Stem Cell Derivation Techniques and Production/Distribution of GMP-Grade Lines
$1,383,419
Quest - Discovery Stage Research Projects
Marisa Medina
iPSCs as a screening tool to predict risk of nonalcoholic fatty liver disease
$813,000
SEED Grant
Miguel Ramalho-Santos
Transcriptional Regulation of Human Embryonic Stem Cells
$595,755
Quest - Discovery Stage Research Projects
Brian Feeley
Matrix Assisted Cell Transplantation of Promyogenic Fibroadipogenic Progenitor (FAP) Stem Cells
$1,179,478
New Faculty II
Emmanuelle Passegue
Mechanisms Underlying the Responses of Normal and Cancer Stem Cells to Environmental and Therapeutic Insults
$2,124,488
Transplantation Immunology
Mark Anderson
Stem cell differentiation to thymic epithelium for inducing tolerance to stem cells
$1,314,089
Early Translational III
Arnold Kriegstein
Human ES cell-derived MGE inhibitory interneuron transplantation for spinal cord injury
$1,623,251
New Faculty Physician Scientist
Ann Zovein
Human endothelial reprogramming for hematopoietic stem cell therapy.
$2,197,683
Shared Labs
Linda Giudice
The University of California San Francisco Shared Research and Teaching Laboratory: a Non-Federal Human Embryonic Stem Cell Resource for the Bay Area Community
$2,144,758
Conference
Peter Stock
IPITA 2013 - 14th World Congress of the International Pancreas and Islet transplant Association
$10,000
Conference
Ophir Klein
Stem Cells Craniofacial Development and Disease
$4,500
Quest - Discovery Stage Research Projects
Shuvo Roy
Silicon Nanopore Membrane encapsulated enriched-Beta Clusters for Type 1 Diabetes treatment
$1,113,000
Clinical Trial Stage Projects
Peter Stock
Pancreatic Islets and Parathyroid Gland Co-transplantation for Treatment of Diabetes in the Intra-Muscular Site: PARADIGM
$11,083,012
New Cell Lines
Long-cheng Li
Induction of pluripotent stem cells by small RNA-guided transcriptional activation
$1,368,461
Cure Sickle Cell Initiative Clinical Trial Stage Projects
Mark Walters
Transplantation of CRISPR-CAS9 Corrected Hematopoietic Stem Cells (CRISPR_SCD001) in Patients with Severe Sickle Cell Disease
$8,389,407
SEED Grant
Thea Tlsty
Role of the tumor suppressor gene, p16INK4a, in regulating stem cell phenotypes in embryonic stem cells and human epithelial cells.
$614,784
Conference II
Rong Wang
22nd International Vascular Biology Meeting
$50,000
Comprehensive Grant
Andrew Leavitt
Understanding hESC-based Hematopoiesis for Therapeutic Benefit
$2,460,822
Transplantation Immunology
Jeffrey Bluestone
Stem cell tolerance through the use of engineered antigen-specific regulatory T cells
$1,152,768
Early Translational III
Holger Willenbring
Generation of safe and therapeutically effective human induced hepatocyte-like cells
$1,544,170
Total:
$252,684,215.00